Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
NCT00003906
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
19747
Enrollment
NETWORK
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Raloxifene
DRUG:
Tamoxifen
Sponsor
NSABP Foundation Inc
Collaborators
[object Object]
[object Object]
[object Object]